Effect of preoperative bisphosphonate therapy on bone mineral density in patients with primary hyperparathyroidism one year after parathyroidectomy
Problems of Endocrinology · 2025
DOI: 10.14341/probl13574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Problems of Endocrinology, 2025. Verfasst von A P Pershina-Miliutina und 6 weiteren Autor:innen. Beteiligte Einrichtung: I.I. Dedov Endocrinology Research Centre. Hauptthemen laut MEDLINE: Bone Density, Parathyroidectomy, Diphosphonates, Hyperparathyroidism, Primary. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: The main treatment for primary hyperparathyroidism (PHPT) is parathyroidectomy (PTE), conservative therapy, including bisphosphonates, can be used for preoperative correction of hypercalcemia, as well as to improve bone tissue condition among individuals for whom surgery should be postponed or cannot be performed due to high perioperative risks. The question of the effect of bisphosphonates on bone tissue after surgery remains open. AIM: To study the effect of preoperative bisphosphonate therapy on BMD parameters assessed in DXA and 3D-DXA in patients with PHPT one year after radical PTE. MATERIALS AND METHODS: The study was conducted on the basis of the Department of pathology of the parathyroid glands and disorders of mineral metabolism of "Endocrinology Research Center" state-funded research facility of the Ministry of Health of the Russian Federation. The study included 50 patients (2 men, 48 women), divided into two groups depending on the presence or absence of preoperative bisphosphonate (BF) therapy. The methods of DXA and 3D-DXA using 3D-Shaper Medical software were used to evaluate BMD and bone microarchitectonics. The statistical analysis was performed using the R language and the Statistica v.13 package. RESULTS: At the time of the disease’s manifestation, both groups were comparable in terms of the main indicators of calcium phosphorus metabolism, with the exception of the level of beta-crosslapse, which was higher in the group without preoperative BPh therapy (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- I.I. Dedov Endocrinology Research Centre.
- Lomonosov Moscow State University.
- I.M. Sechenov First Moscow State Medical University.
Zitieren
APA
Pershina-Miliutina, A. P., Eremkina, A. K., Ozhimalov, I. D., Khairieva, А. V., Gorbacheva, A. M., Ronzhina, S. V., & Mokrysheva, N. G. (2025). Effect of preoperative bisphosphonate therapy on bone mineral density in patients with primary hyperparathyroidism one year after parathyroidectomy. Problems of Endocrinology. https://doi.org/10.14341/probl13574
Vancouver
Pershina-Miliutina AP, Eremkina AK, Ozhimalov ID, Khairieva АV, Gorbacheva AM, Ronzhina SV, et al. Effect of preoperative bisphosphonate therapy on bone mineral density in patients with primary hyperparathyroidism one year after parathyroidectomy. Problems of Endocrinology. 2025. doi:10.14341/probl13574
BibTeX
@article{PershinaMiliutina2025,
author = {Pershina-Miliutina, A P and Eremkina, A K and Ozhimalov, I D and Khairieva, А V and Gorbacheva, A M and Ronzhina, S V and Mokrysheva, N G},
title = {Effect of preoperative bisphosphonate therapy on bone mineral density in patients with primary hyperparathyroidism one year after parathyroidectomy},
journal = {Problems of Endocrinology},
year = {2025},
doi = {10.14341/probl13574}
}
EUVIMED